Tag:
Forbes Medi-Tech
Latest Headlines
Latest Headlines
Forbes Medi-Tech cuts development work in $7M deal
As part of its plan to drop pharmaceutical development work, Forbes Medi-Tech struck a deal to sell its pharmaceutical assets and San Diego facility to Transition Therapeutics for $1 million down and
Forbes Medi-Tech gets out the axe, restructures
Forbes Medi-Tech says it will slash a third of its staff and shelve all in-house drug development work as it focuses its efforts on the nutraceutical business. The shakeup includes a move to shutter
